About 7-dehydrocholesterol reductase
7-dehydrocholesterol reductase (DHCR7) is a protein
from Homo sapiens identified by UniProt accession
Q9UBM7, 475 residues long.
MolForge cross-references it against 0 known binders and
244 disease associations.
Target properties
| Protein name | 7-dehydrocholesterol reductase |
| UniProt accession | Q9UBM7 |
| Gene | DHCR7 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (244)
Diseases linked to this target (Open Targets).
- Smith-Lemli-Opitz syndrome · score 0.88
- vitamin D measurement · score 0.61
- genetic disorder · score 0.55
- neurodegenerative disease · score 0.48
- Cataract · score 0.46
- Intellectual disability · score 0.46
- disorder of sexual differentiation · score 0.46
- 2-3 toe syndactyly · score 0.41
- Elevated circulating 7-dehydrocholesterol concentration · score 0.41
- Small for gestational age · score 0.41
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UBM7-F1 | alphafold | PREDICTED | 91.23 | — |
Amino-acid sequence (475 residues)
MAAKSQPNIP KAKSLDGVTN DRTASQGQWG RAWEVDWFSL ASVIFLLLFA PFIVYYFIMA CDQYSCALTG PVVDIVTGHA RLSDIWAKTP PITRKAAQLY TLWVTFQVLL YTSLPDFCHK FLPGYVGGIQ EGAVTPAGVV NKYQINGLQA WLLTHLLWFA NAHLLSWFSP TIIFDNWIPL LWCANILGYA VSTFAMVKGY FFPTSARDCK FTGNFFYNYM MGIEFNPRIG KWFDFKLFFN GRPGIVAWTL INLSFAAKQR ELHSHVTNAM VLVNVLQAIY VIDFFWNETW YLKTIDICHD HFGWYLGWGD CVWLPYLYTL QGLYLVYHPV QLSTPHAVGV LLLGLVGYYI FRVANHQKDL FRRTDGRCLI WGRKPKVIEC SYTSADGQRH HSKLLVSGFW GVARHFNYVG DLMGSLAYCL ACGGGHLLPY FYIIYMAILL THRCLRDEHR CASKYGRDWE RYTAAVPYRL LPGIF
Explore 7-dehydrocholesterol reductase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets